Astal Laboratories Limited (BOM:512600)

Market Cap	2.98B +287.0%
Revenue (ttm)	2.47B +288.5%
Net Income	147.09M +64.8%
EPS	4.31 -46.4%
Shares Out	43.69M
PE Ratio	15.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,964
Open	73.50
Previous Close	73.85
Day's Range	70.00 - 76.01
52-Week Range	60.45 - 103.20
Beta	-0.45
Analysts	n/a
Price Target	n/a
Earnings Date	May 30, 2026

About Astal Laboratories

Astal Laboratories Limited manufactures and sells pharmaceutical intermediates and bulk drugs in India. The company was formerly known as Macro International Limited and changed its name to Astal Laboratories Limited in April 2024. Astal Laboratories Limited was incorporated in 1993 and is headquartered in Jaipur, India. Astal Laboratories Limited operates as a subsidiary of Aceso Research Labs LLP.

• Industry: Short-Term Business Credit Institutions, Except Agricultural
• Founded: 1993
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 512600

Financial Performance

In fiscal year 2026, Astal Laboratories's revenue was 2.47 billion, an increase of 288.52% compared to the previous year's 636.55 million. Earnings were 147.09 million, an increase of 64.81%.